Charmacy Pharmaceutical Co., Ltd. (HKG:2289)

Charmacy Pharmaceutical Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	4,188	4,385	4,348	4,141	3,763	3,962
Other Revenue	54.92	50.34	56.11	34.61	30.55	29.5
Revenue	4,243	4,435	4,404	4,175	3,794	3,992
Revenue Growth (YoY)	-5.32%	0.72%	5.47%	10.06%	-4.96%	14.29%
Cost of Revenue	3,931	4,115	4,115	3,907	3,560	3,754
Gross Profit	312.58	320.88	288.38	268.61	234.12	237.4
Selling, General & Admin	171.97	175.27	170	162.57	151.85	131.67
Other Operating Expenses	10.06	10.33	9.3	10.07	8.13	6.28
Operating Expenses	181.54	185.67	180.11	175.12	159.69	149.33
Operating Income	131.05	135.21	108.28	93.49	74.42	88.08
Interest Expense	-60.42	-62.46	-41.93	-35.07	-41.52	-31.74
Interest & Investment Income	2.25	3.98	4.3	4.6	3.8	4.02
Currency Exchange Gain (Loss)	-0.27	-0.26	-0.36	-0.75	0.14	0.02
Other Non Operating Income (Expenses)	-5.14	-3.6	-4.11	-6.99	-4.01	-5.67
EBT Excluding Unusual Items	67.46	72.87	66.17	55.28	32.83	54.71
Impairment of Goodwill	-0.03	-0.03	-	-	-	-
Gain (Loss) on Sale of Investments	-	-	-0.1	-	-	-
Gain (Loss) on Sale of Assets	-0.08	0.31	0.05	65.84	0.15	0.02
Asset Writedown	-0.17	-0.33	-0.01	-	-0.01	-
Other Unusual Items	-2.29	-1.62	1.32	0.94	0.01	0.02
Pretax Income	64.89	71.19	67.42	122.05	32.98	54.74
Income Tax Expense	16.62	17.91	16.07	31.58	9.83	14.19
Earnings From Continuing Operations	48.28	53.28	51.34	90.47	23.15	40.56
Net Income	48.28	53.28	51.34	90.47	23.15	40.56
Net Income to Common	48.28	53.28	51.34	90.47	23.15	40.56
Net Income Growth	-6.69%	3.78%	-43.25%	290.76%	-42.91%	1.00%
Shares Outstanding (Basic)	108	108	108	108	108	108
Shares Outstanding (Diluted)	108	108	108	108	108	108
Shares Change (YoY)	0.01%	-0.01%	0.00%	0.01%	-0.01%	0.01%
EPS (Basic)	0.45	0.49	0.48	0.84	0.21	0.38
EPS (Diluted)	0.45	0.49	0.48	0.84	0.21	0.38
EPS Growth	-6.70%	3.79%	-43.25%	290.72%	-42.90%	1.00%
Free Cash Flow	246.78	90.31	-137.39	35.46	-44.58	79.1
Free Cash Flow Per Share	2.29	0.84	-1.27	0.33	-0.41	0.73
Dividend Per Share	0.450	0.450	0.300	0.450	-	0.200
Dividend Growth	50.00%	50.00%	-33.33%	-	-	-
Gross Margin	7.37%	7.23%	6.55%	6.43%	6.17%	5.95%
Operating Margin	3.09%	3.05%	2.46%	2.24%	1.96%	2.21%
Profit Margin	1.14%	1.20%	1.17%	2.17%	0.61%	1.02%
Free Cash Flow Margin	5.82%	2.04%	-3.12%	0.85%	-1.18%	1.98%
EBITDA	150.32	155.71	129.95	121.03	103.52	109.87
EBITDA Margin	3.54%	3.51%	2.95%	2.90%	2.73%	2.75%
D&A For EBITDA	19.27	20.5	21.68	27.54	29.09	21.79
EBIT	131.05	135.21	108.28	93.49	74.42	88.08
EBIT Margin	3.09%	3.05%	2.46%	2.24%	1.96%	2.21%
Effective Tax Rate	25.61%	25.16%	23.84%	25.87%	29.80%	25.91%
Revenue as Reported	4,243	4,435	4,404	4,175	3,794	3,992
Advertising Expenses	-	6.08	11.52	8.89	9.22	3.83

Source: S&P Global Market Intelligence. Standard template. Financial Sources.